AcuityMD Expands AI Tools for MedTech Sales Enhancement
AcuityMD has announced a significant expansion of its AI platform, aimed at enhancing sales performance for medical device companies. The announcement was made at the company's annual Flywheel event, where new AI tools were introduced to provide better visibility into forecasted sales performance, business risks, and strategic actions.
The platform's new capabilities are designed to address challenges faced by MedTech commercial teams, such as fragmented tools and incomplete data, which hinder accurate forecasting and opportunity prioritization. AcuityMD's enhanced AI tools offer reliable forecasts and AI-driven action plans to help leaders focus resources effectively and accelerate revenue growth.
Key features of the expanded platform include generative next-best actions, MedTech-specific forecasting, and an AI voice assistant. These tools guide sales representatives to high-value opportunities, enable precise strategic planning, and convert field observations into structured insights, respectively. The AI recommendation engine continuously learns from interactions, providing smarter and more personalized guidance over time.
The expansion is built on AcuityMD's foundation of real-world market data and advanced targeting technology, offering a powerful layer of insights and guided execution that adapts and improves continuously.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AbbVie Partners With Valkai on AI Tools for Clinical Development
Revenue Growth Agent Calls for AI Deal Intelligence Beyond Call Summaries
AdminaHealth Adds AI Data Assistant to Enterprise Billing Suite
Oracle Health Plans AI Tools for Revenue Cycle Management
Manulife Launches Enterprise AI Platform
Daily AI Brief: the AI news that matters, in your inbox.